Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $1.13, $0.14 better than the analyst estimate of $0.99. Revenue for the quarter came in at $572.1 million versus the consensus estimate of $508.62 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.